Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeStance Health (LFST) Interest Expenses (2020 - 2025)

LifeStance Health (LFST) has disclosed Interest Expenses for 6 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 69.4% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.7 million through Dec 2025, down 56.05% year-over-year, with the annual reading at $11.7 million for FY2025, 56.05% down from the prior year.
  • Interest Expenses for Q4 2025 was $2.9 million at LifeStance Health, up from $2.8 million in the prior quarter.
  • The five-year high for Interest Expenses was $23.2 million in Q2 2021, with the low at $2.8 million in Q3 2025.
  • Average Interest Expenses over 5 years is $5.9 million, with a median of $5.1 million recorded in 2022.
  • The sharpest move saw Interest Expenses surged 316.65% in 2021, then crashed 69.4% in 2025.
  • Over 5 years, Interest Expenses stood at $3.6 million in 2021, then skyrocketed by 43.39% to $5.2 million in 2022, then grew by 7.11% to $5.5 million in 2023, then soared by 69.85% to $9.4 million in 2024, then plummeted by 69.4% to $2.9 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $2.9 million, $2.8 million, and $2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.